🔎 Trials Near Me

Beranda › Kelebihan Berat Badan › California › Concord

Uji klinis Kelebihan Berat Badan di Concord, CA

16 studi untuk Kelebihan Berat Badan mencari peserta di lokasi sekitar Concord (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Menerima pesertaFase 2
  • John Muir Health - Concord /ID# 282469, Concord
  • Diablo Clinical Research /ID# 282530, Walnut Creek · 5 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07752979

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07533175

Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes

Menerima pesertaFase 2
  • Diablo Clinical Research - Flourish Research, Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT07685808

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07720271

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07595549

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Menerima pesertaFase 3
  • Research Site, Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07776509

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07282600

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Menerima pesertaFase 3
  • Research Site, Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07784270

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Menerima pesertaFase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi jauhnya
Usia 45 hingga 99 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07037433

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07353931

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07589608

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Menerima pesertaFase 3
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Sep 2026 · NCT07351045

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Menerima pesertaFase 2
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06143956

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Menerima pesertaFase 3
  • Diablo Clinical Research, Walnut Creek · 5 mi jauhnya
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT07684235

Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to Gastrointestinal Adverse Events

Menerima pesertaFase 1
  • Diablo Clinical Research, Inc., Walnut Creek · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Jun 2026 · NCT07607587

Uji klinis Kelebihan Berat Badan di kota lain

Studi lain di Concord

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.